Skip Navigation
Leading research to understand, treat, and prevent infectious, immunologic, and allergic diseases
Skip Content Marketing
  • Share this:
  • submit to facebook
  • Tweet it
  • submit to reddit
  • submit to StumbleUpon
  • submit to Google +

Biographical Sketches of NIAID Council Members

NIAID welcomes our new Council members for 2015: Amanda Castel, Stephen J. Galli, John Guatelli, and Gurjit Khurana Hershey.

Senior Staff

  • Chairperson: Anthony S. Fauci, M.D., director, NIAID, NIH, DHHS
  • Executive secretary: Matthew J. Fenton, Ph.D., director, DEA, NIAID, NIH, DHHS
  • Ex officio members:
    • Francis S. Collins, M.D., Ph.D., director, NIH, DHHS
    • Other ex officio members are listed beneath their subcommittee.

Acquired Immunodeficiency Syndrome (DAIDS) Subcommittee

Photo Name, Biosketch, and Date Term Ends
Photo of Adaora Adimora, M.D.

Adaora Adimora, M.D., M.P.H., is professor of medicine and epidemiology at the University of North Carolina at Chapel Hill. She is a physician-epidemiologist with specialty training and extensive clinical experience in infectious diseases with a focus on HIV. Her research has characterized the epidemiology of heterosexual HIV transmission among African Americans, highlighted the role of sexual network patterns in the spread of HIV, and underscored the importance of macroeconomic and social forces in racial disparities in the U.S. HIV epidemic. Dr. Adimora serves as chair of the NIH HIV Prevention Trials Network Women at Risk Committee and is a member of the HHS Panel on Antiretroviral Guidelines for Adults and Adolescents. (October 31, 2015)

Photo of DAmanda Castel, M.D., M.P.H.

Amanda Castel, M.D., M.P.H., is associate professor of epidemiology and pediatrics at The George Washington University. She is a medical epidemiologist with training in preventive medicine and applied public health epidemiology. One of Dr. Castel’s research areas is characterizing outcomes along the HIV-care continuum through the use of public health surveillance and clinical data. She also develops interventions to maximize outcomes along the continuum, including routine testing expansion, enhancing retention in care and medication adherence, and reducing community viral load. (October 31, 2018)

Photo of John Guatelli, M.D. John Guatelli, M.D., is professor of medicine at the University of California, San Diego, where he specializes in the clinical aspects of infectious diseases and provides primary care to HIV-infected people. Dr. Guatelli is an expert molecular virologist and recognized for his studies of the HIV-1 proteins Vpu and Nef, which provide the virus with immune-evasion activities. He is well known for sharing in the discovery that BST-2 (tetherin) is the innate host defense protein (restriction factor) that Vpu counteracts to stimulate the release of virus particles from infected cells. (October 31, 2018)
Photo of Jonathan Karn, Ph.D. Jonathan Karn, Ph.D., is Reinberger Professor of Molecular Biology and chair of the Department of Molecular Biology and Microbiology at Case Western Reserve University School of Medicine and director of the Case Center for AIDS Research. Dr. Karn is an expert on HIV molecular biology and is recognized for his studies of HIV transcription and latency. He is well-known for his discovery that the HIV regulatory proteins Tat and Rev are RNA-binding proteins. He served as chair of the NIH AIDS Cell and Molecular Biology Study Section. (October 31, 2015)
Photo of Georgia D. Tomaras, Ph.D.

Georgia D. Tomaras, Ph.D., is associate professor of surgery, immunology, and molecular genetics and microbiology at Duke University Medical Center as well as a faculty member of its Center for Virology and the Computational Biology and Bioinformatics Program. She is also associate director of research and director of the Training and Mentoring Program at the Duke Human Vaccine Institute. The goal of her research program is to understand the cellular and humoral immune responses to HIV-1 infection and vaccination that are involved in protection from HIV-1. Her laboratory focuses on the induction and ontogeny of systemic and mucosal antibody responses and antiviral CD8+ T cell responses. (October 31, 2015)

Photo of Chris Wilson, M.D. Chris Wilson, M.D., is director of the Global Health Discovery and Translational Sciences Program at the Bill and Melinda Gates Foundation. He leads a team that targets fundamental scientific and technological advances in global health to discover new ways to prevent, treat, and diagnose disease. Before coming to the Gates Foundation, Dr. Wilson was chairman of the Department of Immunology at the University of Washington and head of its graduate program in immunology. He has served on several national advisory panels, including the Institute of Medicine Vaccine Safety Review Committee. Dr. Wilson is a member of the Advisory Committee to the Director, NIH. (October 31, 2017)
  Ex officio member:
  • Victoria Davey, Ph.D., M.P.H., chief, Office of Public Health and Environmental Hazards, U.S. Department of Veterans Affairs

Allergy and Immunology (DAIT) Subcommittee

Photo Name, Biosketch, and Date Term Ends
Photo of Maria Laura Acebal, J.D. Maria Laura Acebal, J.D., is the former CEO of the Food Allergy and Anaphylaxis Network (FAAN). She joined FAAN in 2009 and brought with her the nonprofit she founded, Safe@School Partners. Before working in the area of food allergies, Maria worked at the global consulting firm McKinsey & Company and practiced law at Williams & Connolly. (October 31, 2016)
Anita S. Chong, Ph.D. Anita S. Chong, Ph.D., is professor of surgery at the University of Chicago. She is a transplant immunologist with research interests in transplantation tolerance, how infection promotes rejection, maintaining tolerance, and defining new therapies to prevent solid organ rejection. Dr. Chong’s research includes a multidisciplinary effort to apply new nanotechnologies to develop self-adjuvanting vaccines for infectious diseases. She has served on several grant review committees and is co-chair of the Basic Science Committee of the Transplantation Society. (October 31, 2017)
Photo of Stephen J. Galli, M.D.

Stephen J. Galli, M.D., is Mary Hewitt Loveless, M.D., Professor; chair and professor of pathology; and professor of microbiology and immunology at Stanford University. He investigates the roles of mast cells and basophils in health and disease, including in host defense and allergic disorders such as food allergy and asthma. Dr. Galli has been a member or chair of NIH study sections and co-chaired an NIAID Food Allergy Research Expert Panel. He belongs to the Collegium Internationale Allergologicum where he served as president from 2010 to 2014, Institute of Medicine of the U.S. National Academy of Sciences, and Accademia Nazionale dei Lincei. (October 31, 2018)

Photo of Gurjit Khurana Hershey, M.D., Ph.D.

Gurjit Khurana Hershey, M.D., Ph.D., is Kindervelt Endowed Chair in Asthma Research and professor of pediatrics at Cincinnati Children's Hospital Medical Center and the University of Cincinnati College of Medicine. She is also director of the Medical Scientist Training Program at the University of Cincinnati and co-director of the Office of Pediatric Clinical Fellowships at Cincinnati Children's Hospital Medical Center. Dr. Khurana Hershey’s research focuses on the overall goal of improving the health of children with asthma. Her laboratory integrates clinical, epidemiologic, translational, and basic research approaches to identify and delineate the mechanistic basis of genetic and environmental factors that contribute to the development, progression, and persistence of asthma. (October 31, 2018)

Arlene Sharpe, M.D., Ph.D.

Arlene Sharpe, M.D., Ph.D., is George Fabyan Professor of Comparative Pathology at Harvard Medical School. She is also head of the Division of Immunology in the Department of Microbiology and Immunobiology and co-director of the Harvard Institute of Translational lmmunology. Dr. Sharpe is a leader in the field of costimulation. Her laboratory currently focuses on the roles of T cell costimulatory pathways in regulating pathogenic and protective immune responses needed for inducing and maintaining T cell tolerance and effective antimicrobial and antitumor immunity. Her laboratory is also involved in studies aimed at translating fundamental understanding of T cell costimulation into new therapies for autoimmune diseases, chronic viral infections, and tumor immunotherapy. (October 31, 2017)

No photo available. Vacant

Microbiology and Infectious Diseases (DMID) Subcommittee

Photo Name, Biosketch, and Date Term Ends
Photo of Mavis Agbandje-McKenna, Ph.D.

Mavis Agbandje-McKenna, Ph.D., is professor in the Department of Biochemistry and Molecular Biology and director of the Center for Structural Biology in the College of Medicine at the University of Florida. Her laboratory uses structural biology and biophysical tools combined with biochemistry and molecular biology to study single-stranded DNA viruses. The goal of her research is to obtain a fundamental understanding of the virus and host determinants of tissue tropism, host adaptation, host pathogenicity, and virus-host immune system interactions. (October 31, 2015)

Photo of Norman W. Baylor, Ph.D.

Norman W. Baylor, Ph.D., is president and CEO of Biologics Consulting Group, Inc. Previously, Dr. Baylor was the director of the Office of Vaccines Research and Review in the Food and Drug Administration’s Center for Biologics Evaluation and Research. He evaluated and facilitated the development and licensure of numerous vaccines. Dr. Baylor served as FDA’s liaison to CDC’s Advisory Committee on Immunization Practices, U.S. Department of Health and Human Services National Vaccine Advisory Committee, and the Advisory Commission on Childhood Vaccines. He also served as an expert advisor to the World Health Organization on several global vaccine initiatives. (October 31, 2016)

Photo of Robert B. Belshe, M.D. Robert B. Belshe, M.D., is professor of medicine, pediatrics, and molecular microbiology and director of the Center for Vaccine Development at Saint Louis University. He is principal investigator of the NIH-funded Vaccine and Treatment Evaluation Unit at the University. Dr. Belshe is an expert in clinical trials design and execution, and his laboratory focuses on antibody responses to viral vaccines, particularly influenza. He conducted the vaccinia dilution studies for the NIH biodefense initiative and chaired the NIH/industry cooperative phase III pivotal licensing studies on live attenuated influenza vaccine and the NIH and GlaxoSmithKline Herpevac Trial for Women. (October 31, 2016)
Photo of Diane E. Griffin, M.D., Ph.D. Diane E. Griffin, M.D., Ph.D., is university distinguished service professor and Alfred and Jill Sommer Chair of the W. Harry Feinstone Department of Molecular Microbiology and Immunology at the Johns Hopkins Bloomberg School of Public Health. Dr. Griffin’s research interests focus on the pathogenesis of viral diseases, particularly measles and alphavirus encephalitis. Her studies address issues related to virulence and the role of immune responses in protection from infection and clearance of infection. Dr. Griffin is U.S. chair of the Viral Diseases Panel of the U.S.-Japan Cooperative Medical Sciences Program and a member of the Councils for the National Academy of Sciences and the Institute of Medicine. (October 31, 2016)
Larry S. Schlesinger, M.D.

Larry S. Schlesinger, M.D., is Samuel Saslaw Professor and chair of the Department of Microbial Infection and Immunity in the College of Medicine at The Ohio State University. He also serves as director of the OSU Center for Microbial Interface Biology and Medical Scientist Training Program. Dr. Schlesinger is a cellular immunologist whose studies focus on the pathogenesis of tuberculosis and other airborne infections caused by intracellular pathogens that subvert lung immune mechanisms. He has been a member or chair of several study sections at NIH and other federal and private agencies. (October 31, 2017)

No photo available. Vacant
  Ex officio members:
  • Bruce G. Gellin, M.D., M.P.H., director, National Vaccine Program Office, Office of Public Health and Science, Office of the Assistant Secretary for Health, DHHS
  • Rima Khabbaz, M.D., deputy director for infectious diseases, Centers for Disease Control and Prevention

For more information, see the Advisory Council portal.​​​

Last Updated February 24, 2015

Last Reviewed July 08, 2015